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ABSTRACT
Background: The medical kit is the basis of medical support in maritime environment; it is defined by inter-
national or national regulations and guidelines. For offshore races, rules and recommendations are propo-
sed by national or international sailing federations. Sailing and racing offshore alone presents specificities 
that sometimes make it difficult to apply the usual recommendations. The epidemiology of single-handed 
offshore race is dominated by traumatic risks. Medical events are relatively rare because competitors are 
high-level athletes, generally young and subject to complete medical assessments. The scarcity of available 
scientific data makes it necessary to choose appropriate methods for developing recommendations. The 
purpose of this work is to propose a medical kit adapted and applicable to these situations.
Materials and methods: The method used was that of “Professional recommendations by formal consen-
sus of experts” derived from the Rand/UCLA method. After a critical analysis of the literature, a panel 
of 19 experts having expertise in medicine in maritime environment was gathered from various medical 
specialties (cardiologist, internist, intensivist and emergency physician, ear-nose-throat physician and  
general practitioner) and from varied medical activities. They had not declared any direct conflict of interest. 
Results: A medical kit proposal has been developed. The choice of drugs was based on the analysis of 
the epidemiology of medical events observed during the last offshore races. The experts’ choice was to 
reduce the quantity of medication and medical devices in order to limit the risk of confusion of medicines 
and dosages. Drugs with significant side effects or requiring third party monitoring have been removed. 
Medical devices designed to do an intervention impossible to perform on oneself have also been eliminated.
Conclusions: Solo sailing remains a marginal maritime activity with specific risks. The development of 
single-handed races requires an adaptation of medical support through the development of a specific me-
dical kit and adapted training. The formalised consensus of experts seems to be an appropriate method 
for developing recommendations in the field of maritime medicine.
(Int Marit Health 2019; 70, 4: 220–225)
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INTRODUCTION
The medical kits, with medical training and telemedical 
advices, are the basis of the medical support in the maritime 
environment. They are defined by international or national 
regulations [1, 2]. Scientific societies have also proposed 
recommendations mainly in the field of cruising. For offshore 
yacht races regulations and recommendations are proposed 
by the national or international federations [3]. The practice 
of single-handed offshore races presents specificities that 
sometimes make it difficult to apply the usual recommen-
dations. The epidemiology of single-handed offshore races 
is dominated by traumatic risks [4, 5]. Medical events, 
apart from dermatological problems [6], are rare because 
skippers are high-level athletes, generally young and subject 
to full medical assessments. The purpose of this work is to 
propose a medical kit adapted and applicable to this activity.
MATERIALS AND METHODS 
The method used was that of “Professional recommen-
dations by formal consensus of experts” derived from the 
Rand/UCLA method. After a critical analysis of the literature, 
a panel of 18 experts (Appendix 1) having expertise in med-
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icine in maritime environment was gathered from various 
medical specialties (cardiologist, internist, intensivist and 
emergency physician, ear-nose-throat physician and gen-
eral practitioner) and from varied medical activities. They 
had not declared any direct conflict of interest. The members 
of the rating group were required to complete the question-
naires submitted to them in their entirety. Next to each item 
of the questionnaire is placed a numerical scale graduated 
from 1 to 9, the value 1 means that the contributor judges 
the proposal totally inappropriate (or not indicated, or not 
acceptable), the value 9 means that the contributor judges 
the proposal is entirely appropriate (or indicated, or accept-
able), the values 2 to 8 reflect the possible intermediate 
situations, the value 5 corresponds to the indecision of 
the contributor. Two rounds of quotation are carried out. 
The final ranking of the various proposals was made by 
calculating the median and the distribution of quotations 
in strong agreement, relative agreement, indecision, lack of 
consensus. For the final recommendations, only proposals 
with strong or relative agreement were selected [7].
RESULTS
A proposal for a medical kit has been developed (Table 1). 
The organisation of the kit should allow for intuitive use, 
possibly using colour-coded modular arrangements, and 
should include an easily accessible list of content. The drugs 
are listed Anatomical Therapeutic Chemical (ATC) code (The 
ATC Classification System) [8] and by generic name followed 
by the indication for use and whether or not to contact the 
Telemedical Advice Service (TMAS) before a procedure or 
administration of a drug.
DISCUSSION
The choice of the medicines was based on the analysis 
of the epidemiology of medical events observed during the 
last offshore races [4, 5, 6, 9]. In the same therapeutic 
class, an analysis of the recent recommendations of learned 
societies or health authority organisations has made it 
possible to choose the most relevant medicine according 
to evidence-based medicine. The experts’ choice was to 
reduce the quantity of medicines and medical devices in 
order to limit the risks of confusion of the medicines and 
their dosages, taking into account the limited space and 
weight allotment on board, and the cost to the skippers for 
whom it is not a priority. Medicines with significant side ef-
fects or requiring special monitoring have been eliminated. 
Medical devices designed to perform techniques impos-
sible to execute on oneself have also been eliminated. The 
other criteria of choice were to promote a compact and light 
presentation, biochemically and environmentally stable. 
These recommendations represent the basic minimum 
endowment, and can be supplemented according to local 
regulations or requests from race organisers. Skippers with 
specific pathologies and who have passed the selection 
tests will have to complete the medical kit by the specific 
drugs of their pathologies.
CARDIOVASCULAR DRUGS
They are present in all medical kit for the management of 
heart failure, acute coronary syndrome or a rhythm disorder. 
In the case of single handed offshore race, epidemiology 
[5, 9] does not show any major cardiovascular events, al-
though they are still possible. The population of offshore 
skippers is essentially a young population, high-level ath-
letes, prepared and medically followed before their depar-
ture. In addition, if an acute coronary syndrome occurred it 
would be difficult to start an anti-platelet or anticoagulant 
treatment with haemorrhagic risks without diagnostic con-
firmation. Only DL-lysine acetylsalicylate acid in oral sachet 
was kept [10]. The furosemide, often recommended, has not 
been retained, the possibility of cardiac or renal decompen-
sation with hydro saline inflation that would not have been 
revealed before the race is unlikely, the risk in the maritime 
environment is rather the risk of dehydration.
ANALGESICS
Level one is represented by paracetamol, for more in-
tense pain paracetamol/nonsteroidal anti-inflammatory 
drugs combination is recommended [11, 12]. In case of 
major pain or failure of previous measures, an opioid, mor-
phine sulphate 10 mg, should be administered. Given the 
risk of side effects and the difficulty of performing a titration 
under good conditions, the choice of the oral route is pre-
ferred. To avoid any risk of confusion and overdose, all other 
medicines have been eliminated as well as presentations 
involving several medicines.
PSyCHOTROPIC AND SEDATIVE DRUGS
Psychotropic agents and anxiolytic sedatives, mainly ben-
zodiazepines, are proposed in medical kit for the management 
and treatment of agitation states, panic attacks or sleep disor-
ders [13]. These drugs can be useful in commercial navigation 
or crewed sailing but can be dangerous in solitary navigation. 
They can lead to a decrease in alertness and combativeness 
and drowsiness, more rarely can they be responsible for par-
adoxical effects and hallucinations [13]. For all these reasons 
they have been eliminated from the medical kit.
VASOPRESSIVE CATECHOLAMINES
The only indication in these situations is the treatment, 
in emergency, of acute anaphylaxis (stage II and III) of food 
or drug origin. Under these conditions, the recommended 
medicine is adrenaline in intramuscular injectable solution 
with 0.3 mg pre filled syringes in self-injectable device, two 
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Table 1. Recommended medicines and equipment on board off-shore racing yachts
Medical Support for single-handed Offshore Yacht Races — Medical Kit Inventory*
X indicates that Telemedical Advice Service (TMAS) should be contacted before a procedure or administering a drug. 
LIST OF RECOMMENDED MEDICINES AND EQUIPMENT ON BOARD OFF-SHORE RACING yACHTS
World Health Organization Format
Item 
no.
ATC code Recommended medicine and  
dosage strength representing best pra-
ctice on board off-shore racing yachts 




1 A02AE03 Lansoprazole 30 mg tablet To treat gastro-oesophageal reflux; to treat ulcer disease x
2 A03AX12 Phloroglucinol 80 mg To relieve intestinal or urinary spasms x
3 A06AB02 Bisacodyl 5 mg tablet For treatment of constipation
4 A07CA Oral rehydration salts sachets To prevent or treat dehydration
5 A07XA04 Radecadotril 100 mg tablet Antidiarrheals
6 C05AX Haemorrhoid preparations — proprietary 
preparation of choice
Haemorrhoid preparations
7 B02AA02 Tranexamic acid tablet 500 mg Treatment of haemorrhage x
8 C01CA24 Adrenaline auto-injector 0.5 mg To raise blood pressure in anaphylaxis; to dilate airways  
in severe asthma or anaphylaxis
9 D01AC02 Miconazole 2% ointment (30 g) To treat fungal skin infections
10 D06BA01 Silver sulfadiazine cream (50 g) Treatment of burns
11 D06BB03 Acyclovir 5% cream (10 g) To treat cold sores x
12 G01AF02 Clotrimazole 500 mg pessary To treat vaginal fungal infections x
13 J01XX01 Fosfomycin tablet Single dose treatment of uncomplicated acute cystitis in women x
14 J01CR02 Amoxicillin + clavulanate 1000/200 To treat infections responsive to this antibiotic x
15 J01DD04 Ceftriaxone 1 g ampoule To treat infections responsive to this antibiotic x
16 J01FG01 Pristinamycin tablets 500 mg To treat infections responsive to this antibiotic x
17 J01MA02 Ciprofloxacin 500 mg tablet To treat infections responsive to this antibiotic x
18 P01AB01 Metronidazole 400 mg tablet To treat intestinal infections responsive to this antibiotic x
19 H02AB07 Prednisone 10 mg tablet To treat severe asthma; to treat other inflammatory conditions x
20 M01AE01 Ibuprofen 400 mg tablet To treat inflammation; to reduce mild to moderate pain,  
especially if associated with inflammation
21 N01BB02 Lignocaine gel (6 mL) Local anaesthetic
22 N02AA01 Morphine sulphate (oral) tablet 10 mg Opioid analgesic (treatment of moderate to severe pain) x
23 N02BA01 Acetylsalicylic acid 300 mg To inhibit formation of blood clots in angina pectoris,  
myocardial infarction, stroke
x
24 N02BE01 Paracetamol 1 g tablet To reduce pain and fever
25 N07CA02  Cinnarizine 25 mg tablet To prevent and treat motion-sickness
26 R06AE07 Cetirizine tablet 10 mg Anti-histaminic, anti-allergic x
27 S01AA09 Tetracycline eye ointment (4 g) Eye infection x
28 S01AA16 Rifamycin ophthalmic ointment Eye infection antiinfective preparations for ophthalmological use x
29 S01CA01 Tobramycin/Dexamethasone eye/ear 
drops (10 mL) 
To treat eye and ear infections x
30 S01XA02 Retinol eye ointment Topical preparation for repairing eye x
31 S02AA12  Rifamycin ear drop Ear infection
Æ
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LIST OF RECOMMENDED MEDICINES AND EQUIPMENT ON BOARD OFF-SHORE RACING yACHTS
World Health Organization Format
Item 
no.
ATC code Recommended medicine and  
dosage strength representing best pra-
ctice on board off-shore racing yachts 




DRESSING MATERIAL AND SUTURING EqUIPMENT
32 Wound closure strips Adhesive skin closures
33 Skin stapler × 35 staples Wound staplers
34 Stapler remover Wound staplers
35 Assorted wound plasters Adhesive dressing
36 Adhesive wound dressing 10 × 10 cm Adhesive dressing
37 Sterile gauze compresses 10 × 10 cm Sterile gauze compresses
38 Low adherent dressing 10 × 10 cm Gauze dressing with non-adherent surface
39 Tulle gras dressing Healing dressing
40 Haemostatic dressing Haemostatic agent
41 Elastic fixation bandage 6 cm × 4 m Bandage
42 Tubular bandage 5, 8, 10 cm × 10 m Bandage
43 Adhesive surgical tape 2.5 cm × 10 m Bandage
44 Chlorhexidine solution S02AA09 Antiseptic 
45 Sterile gauze swabs 5 × 5 cm Sterile swabs
46 Adhesive elastic bandage 7.5 cm × 4.5 m Bandage
47 Cohesive bandage 7.5 cm × 4.5 cm Bandage
48 Trauma tourniquet Compressing device (bandage), to control bleeding 
49 Gloves non-sterile, disposable Gloves
INSTRUMENTS
50 Bandage scissors (tough cut scissors) Scissors
51 Artery clamp Haemostatic clamp
52 Splinter forceps (tweezer) Forceps
53 Scalpel, sterile, disposable Disposable scalpels
EXAMINATION AND MONITORING EqUIPMENT
54 Stethoscope
55 Sphygmomanometer manual Blood pressure set
56 Sphygmomanometer automatic Blood pressure set
57 Large blood pressure cuff Blood pressure cuff
58 Thermometer digital Thermometer
59 Pulse oximeter For monitoring of oxygen saturation
60 Urine testing strips 10 parameters Reactive strips for urine analysis
61 Blood glucose testing kit/25 strips + 25 needles Reactive strips for blood analysis
EqUIPMENT FOR INJECTION, INFUSION AND CATHETERISATION
62 Syringes 5 mL Equipment for injection
63 Needle 23 G hypodermic Equipment for injection
64 Needle subcutaneous Equipment for infusion x
Table 1. cont. Recommended medicines and equipment on board off-shore racing yachts
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LIST OF RECOMMENDED MEDICINES AND EQUIPMENT ON BOARD OFF-SHORE RACING yACHTS
World Health Organization Format
Item 
no.
ATC code Recommended medicine and  
dosage strength representing best pra-
ctice on board off-shore racing yachts 
Indications on board off-shore racing yachts Need to  
contact
TMAS
GENERAL MEDICAL AND NURSING EqUIPMENT
65 Ethanol 70% hand cleanser gel 250 mL An alternative to hand washing
66 Medical guide
67 Medical observation forms  
68 Cold pack To reduce swelling and pain
69 Dental repair kit x
IMMOBILISATION AND TRANSPORTATION EqUIPMENT
70 Malleable splint For immobilizing bone and soft tissue injuries
71 Neck collar, semi-rigid, adjustable For neck immobilisation
*List of recommended medicines and equipment as stated in SFMM Consensus Paper on Medical Support for Single handed Off Shore Yacht Races – Medical Kit Inventory
Table 1. cont. Recommended medicines and equipment on board off-shore racing yachts
doses must be available and the treatment must be carried 
out in connection with a TMAS.
DEVICES AND PERFUSION SOLUTION
The setting up of an intravenous and prolonged infusion 
seems difficult to achieve in single-handed navigation and 
not without danger. Emphasis should be placed on the 
early detection of dehydration states and its correction by 
electrolytic supply via the digestive tract.
It was not included in these proposals anything which 
relates to hygiene products (sunscreen, lipstick, dermato-
logical soap, hand protection products and for seat and 
feet). No survival bag has been proposed as in some other 
recommendations.
CONCLUSIONS
The single-handed offshore yacht race remains a mar-
ginal practice with specific risks. The development of this 
type of races requires an adaptation of medical support 
through the development of a specific medical kit with 
adapted training. The formal consensus of experts seems 
to be an appropriate method for the development of rec-
ommendations in the field of maritime medicine. The 
evolution of the medical kits over time is inevitable by 
adapting to the new epidemiological collections available 
and according to the evolution of the human constraints 
of the boats.
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AppendiX 1.  SFMM Position Paper. Medical Support for single handed Offshore Yacht Races — Expert group
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